Lockdown effect on people with type 2 diabetes prompts call for ‘crucial’ access to diabetes technology
Reports that people with type 1 diabetes experienced better blood sugar control during lockdown while glycaemic control worsened in those with type 2 has led to calls for better access to diabetes technology for all.
Diabetes UK has responded to findings presented at the Annual Meeting of the European Association for the Study of Diabetes, which show that blood sugar control improved during lockdown in those with type 1 diabetes.
Nikki Joule, Policy Manager at Diabetes UK, said: “This study offers important insights into how people living with diabetes were able to manage their condition during lockdown. While people living with type 1 diabetes had overall improved management, lockdown appears to have had a detrimental effect on diabetes management for those living with type 2 diabetes.
“Diabetes technologies can have a really positive impact on blood sugar management and wellbeing. It is crucial that everyone who might benefit from diabetes tech has access to it, and these findings among those with type 1 diabetes reiterate just how pivotal diabetes tech can be.
“It’s worrying that lockdown had a negative impact on diabetes management for those with type 2 diabetes. The backlog in routine diabetes care must urgently be addressed, so that those living with diabetes can access the support and care they need.”
Earlier this month, the Diabetes Times reported on a study by a German research team which looked at the impact of the COVID-19 lockdown on glycaemic control in people with diabetes and found that while people with type 1 diabetes saw “significant” improvements in glycaemic values, those with type 2 were adversely affected.
The latest discussions around the impact of COVID-19 on people with diabetes follows recent findings that 2.5m diagnostic tests for diabetes were missed or delayed during lockdown, and more than a million people with the condition missed routine blood tests.